Abstract:Research performed in Europe has driven cardiovascular device innovation. This includes, but is not limited to, percutaneous coronary intervention, cardiac imaging, transcatheter heart valve implantation, and device therapy of cardiac arrhythmias and heart failure. An important part of future medical progress involves the evolution of medical technology and the ongoing development of artificial intelligence and machine learning. There is a need to foster an environment conducive to medical technology development and validation so that Europe can continue to play a major role in device innovation while providing high standards of safety. This paper summarizes viewpoints on the topic of device innovation in cardiovascular medicine at the European Society of Cardiology Cardiovascular Round Table, a strategic forum for high-level dialogue to discuss issues related to the future of cardiovascular health in Europe. Devices are developed and improved through an iterative process throughout their lifecycle. Early feasibility studies demonstrate proof of concept and help to optimize the design of a device. If successful, this should ideally be followed by randomized clinical trials comparing novel devices vs. accepted standards of care when available and the collection of post-market real-world evidence through registries. Unfortunately, standardized procedures for feasibility studies across various device categories have not yet been implemented in Europe. Cardiovascular imaging can be used to diagnose and characterize patients for interventions to improve procedural results and to monitor devices long term after implantation. Randomized clinical trials often use cardiac imaging-based inclusion criteria, while less frequently trials randomize patients to compare the diagnostic or prognostic value of different modalities. Applications using machine learning are increasingly important, but specific regulatory standards and pathways remain in development in both Europe and the USA. Standards are also needed for smart devices and digital technologies that support device-driven biomonitoring. Changes in device regulation introduced by the European Union aim to improve clinical evidence, transparency, and safety, but they may impact the speed of innovation, access, and availability. Device development programmes including dialogue on unmet needs and advice on study designs must be driven by a community of physicians, trialists, patients, regulators, payers, and industry to ensure that patients have access to innovative care.

Medical device regulation in vascular ageing assessment: a VascAgeNet survey exploring knowledge and perception

Developing technologies to assess vascular ageing: a roadmap from VascAgeNet

Quality and Utility of European Cardiovascular and Orthopaedic Registries for the Regulatory Evaluation of Medical Device Safety and Performance Across the Implant Lifecycle: A Systematic Review

Translational Science in Vascular Aging: From Bench to Bedside—Insights from a VascAgeNet Roundtable

Device regulation and surveillance in vascular care: Challenges and opportunities

New medical device regulations: the regulator’s view

Research methodology and practical issues relating to the conduct of a medical device registry

The Challenges for Manufacturers of the Increased Clinical Evaluation in the European Medical Device Regulations: A Quantitative Study

Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table

Recent regulatory developments in EU Medical Device Regulation and their impact on biomaterials translation

Vascular senescence and atherosclerotic plaque vulnerability: investigating the telomere-mitochondria crosstalk—rationale and design of the VICTORIA Study

Is medical device regulatory compliance growing as fast as extended reality to avoid misunderstandings in the future?

A review of the literature on the new European Medical Device Regulations requirements for increased clinical evaluation

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Challenges faced by manufacturers with clinical evaluation under the new European Medical Device Regulations

Regulatory considerations for developing remote measurement technologies for Alzheimer's disease research

Medical Device Apps: An Introduction to Regulatory Affairs for Developers

The European Medical Device Regulation–What Biomedical Engineers Need to Know

Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE–MD (Coordinating Research and Evidence for Medical Devices)

The Concept of Early Vascular Ageing – An Update in 2015

Regulatory perspectives on post-market evidence generation schemes for high-risk medical devices: a systematic review